The original success of Viagra undeniably reshaped the medication landscape, but betting in companies strongly reliant on off-patent versions presents a challenging picture. Despite early earnings were significant, the end of patents and the rise of discounted alternatives have weakened market share. Therefore, a thorough assessment of ongoing fina